F. Ibrahim, L. Hamzah, R. Jones, D. Nitsch, C. Sabin et al., Baseline kidney function as predictor of mortality and kidney disease progression in HIVpositive patients, Am J Kidney Dis oct, vol.60, issue.4, pp.539-586, 2012.

N. Wearne, C. R. Swanepoel, A. Boulle, M. S. Duffield, and B. L. Rayner, The spectrum of renal histologies seen in HIV with outcomes, prognostic indicators and clinical correlations, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Ren Assoc, vol.27, issue.11, pp.4109-4127, 2012.

S. K. Mallipattu, F. Salem, and C. M. Wyatt, The changing epidemiology of HIVrelated chronic kidney disease in the era of antiretroviral therapy, Kidney Int, vol.86, issue.2, pp.259-65, 2014.

L. I. Gardner, S. D. Holmberg, J. M. Williamson, L. A. Szczech, C. Carpenter et al., Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women, J Acquir Immune Defic Syndr, vol.32, issue.2, pp.203-212, 2003.

A. Choi, R. Scherzer, P. Bacchetti, P. C. Tien, M. S. Saag et al., Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons, Am J Kidney Dis, vol.56, issue.5, pp.872-82, 2010.
DOI : 10.1053/j.ajkd.2010.05.019

URL : http://europepmc.org/articles/pmc3164880?pdf=render

U. E. Ekrikpo, A. P. Kengne, A. K. Bello, E. E. Effa, J. J. Noubiap et al., Chronic kidney disease in the global adult HIV-infected population: a systematic review and meta-analysis, PLoS One, vol.13, issue.4, p.195443, 2018.

F. M. Islam, J. Wu, J. Jansson, and D. P. Wilson, Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis, BMC Public Health, vol.12, p.234, 2012.

S. K. Mallipattu, C. M. Wyatt, and J. C. He, The new epidemiology of HIV-related kidney disease, J AIDS Clin Res, p.1, 2012.

A. Ganesan, E. M. Krantz, H. Hullsiek, K. Riddle, M. S. Weintrob et al., Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care, HIV Med, vol.14, issue.2, pp.65-76, 2013.

J. Coresh, B. C. Astor, T. Greene, G. Eknoyan, and A. S. Levey, Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and nutrition examination survey, Am J Kidney Dis, vol.41, issue.1, pp.1-12, 2003.

A. Mocroft, J. D. Lundgren, M. Ross, M. Law, P. Reiss et al., Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:a:D study, PLoS Med, vol.12, issue.3, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01934825

W. Pongpirul, K. Pongpirul, J. Ananworanich, V. Klinbuayaem, A. Avihingsanon et al., Chronic kidney disease incidence and survival of Thai HIVinfected patients, AIDS Lond Engl, vol.32, issue.3, pp.393-401, 2018.

A. Reid, W. Stöhr, A. S. Walker, I. G. Williams, C. Kityo et al., Severe renal dysfunction and risk factors associated with renal impairment in HIVinfected adults in Africa initiating antiretroviral therapy, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.46, issue.8, pp.1271-81, 2008.

P. Flandre, P. Pugliese, L. Cuzin, C. I. Bagnis, I. Tack et al., Risk factors of chronic kidney disease in HIV-infected patients, Clin J Am Soc Nephrol, vol.6, issue.7, pp.1700-1707, 2011.

R. C. Kalayjian, B. Lau, R. N. Mechekano, H. M. Crane, B. Rodriguez et al., Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care, AIDS Lond Engl, vol.26, issue.15, pp.1907-1922, 2012.

R. D. Cooper, N. Wiebe, N. Smith, P. Keiser, S. Naicker et al., Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.51, issue.5, pp.496-505, 2010.

R. Scherzer, M. Estrella, Y. Li, A. I. Choi, S. G. Deeks et al., Association of tenofovir exposure with kidney disease risk in HIV infection, AIDS Lond Engl, vol.26, issue.7, pp.867-75, 2012.

A. Mocroft, O. Kirk, P. Reiss, D. Wit, S. Sedlacek et al., Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients, AIDS Lond Engl, vol.24, issue.11, pp.1667-78, 2010.

A. Mocroft, J. D. Lundgren, M. Ross, C. A. Fux, P. Reiss et al., Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study, Lancet HIV, vol.3, issue.1, pp.23-32, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01908643

T. Nishijima, Y. Kawasaki, N. Tanaka, D. Mizushima, T. Aoki et al., Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight: results from 10 years of follow-up, AIDS Lond Engl, vol.28, issue.13, pp.1903-1913, 2014.

C. Laprise, J. Baril, S. Dufresne, and H. Trottier, Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.56, issue.4, pp.567-75, 2013.

A. Cournil, A. Hema, S. Eymard-duvernay, L. Ciaffi, S. Badiou et al., Evolution of renal function in African patients initiating second-line antiretroviral treatment: findings from the ANRS 12169 2LADY trial, Antivir Ther, vol.22, issue.3, pp.195-203, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01808791

L. Ryom, A. Mocroft, O. Kirk, S. W. Worm, D. A. Kamara et al., Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:a:D study, J Infect Dis, vol.207, issue.9, pp.1359-69, 2013.
DOI : 10.1093/infdis/jit043

URL : https://hal.archives-ouvertes.fr/hal-01101122

, National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am J Kidney Dis, vol.39, issue.2, pp.1-266, 2002.

A. S. Levey, J. Coresh, T. Greene, J. Marsh, L. A. Stevens et al., Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values, Clin Chem, vol.53, issue.4, pp.766-72, 2007.

, Definition and classification of CKD, Kidney Int Suppl, vol.3, issue.1, pp.19-62, 2013.

S. Rabe-hesketh and A. Skrondal, Multilevel and Longitudinal Modeling Using Stata (3rd Edition). Volume I: continuous responses, 2012.

L. Ciaffi, S. Koulla-shiro, A. B. Sawadogo, C. T. Ndour, S. Eymard-duvernay et al., Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/ MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial, Lancet HIV, vol.4, issue.9, pp.384-92, 2017.

R. De-waal, K. Cohen, M. P. Fox, K. Stinson, G. Maartens et al., Changes in estimated glomerular filtration rate over time in south African HIV-1-infected patients receiving tenofovir: a retrospective cohort study, J Int AIDS Soc, vol.20, issue.1, p.21317, 2017.

L. Mulenga, P. Musonda, A. Mwango, M. J. Vinikoor, M. Davies et al., Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.58, issue.10, pp.1473-80, 2014.

J. B. Eastwood, S. M. Kerry, J. Plange-rhule, F. B. Micah, S. Antwi et al., Assessment of GFR by four methods in adults in Ashanti, Ghana: the need for an eGFR equation for lean African populations, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Ren Assoc, vol.25, issue.7, pp.2178-87, 2010.

J. Cailhol, B. Nkurunziza, H. Izzedine, E. Nindagiye, L. Munyana et al., Prevalence of chronic kidney disease among people living with HIV/ AIDS in Burundi: a cross-sectional study, BMC Nephrol, vol.12, p.40, 2011.

U. E. Ekrikpo, A. P. Kengne, E. E. Akpan, E. E. Effa, A. K. Bello et al., Prevalence and correlates of chronic kidney disease (CKD) among ART-naive HIV patients in the Niger-Delta region of Nigeria, Medicine (Baltimore), issue.16, p.97, 2018.

S. Jose, L. Hamzah, R. Jones, D. Williams, A. Winston et al., Chronic kidney disease risk in African and Caribbean populations with HIV, J Infect Dis, vol.218, issue.11, pp.1767-72, 2018.
DOI : 10.1093/infdis/jiy397

URL : https://academic.oup.com/jid/article-pdf/218/11/1767/26120267/jiy397.pdf

W. Stöhr, A. S. Walker, P. Munderi, S. Tugume, C. F. Gilks et al., Estimating glomerular filtration rate in HIV-infected adults in Africa: comparison of Cockcroft-gault and modification of diet in renal disease formulae, Antivir Ther, vol.13, issue.6, pp.761-70, 2008.

C. M. Wyatt, Q. Shi, J. E. Novak, D. R. Hoover, L. Szczech et al., Prevalence of kidney disease in HIV-infected and uninfected Rwandan women, PloS One, vol.6, issue.3, p.18352, 2011.

F. S. Sarfo, R. Keegan, L. Appiah, S. Shakoor, R. Phillips et al., High prevalence of renal dysfunction and association with risk of death amongst HIV-infected Ghanaians, J Infect, vol.67, issue.1, pp.43-50, 2013.

D. S. Ayokunle, O. T. Olusegun, A. Ademola, C. Adindu, R. M. Olaitan et al., Prevalence of chronic kidney disease in newly diagnosed patients with human immunodeficiency virus in Ilorin, Nigeria, J Bras Nefrol Orgao Of Soc Bras E Lat Am Nefrol, vol.37, issue.2, pp.177-84, 2015.

T. A. Adedeji, N. O. Adedeji, S. A. Adebisi, A. A. Idowu, M. B. Fawale et al., Prevalence and pattern of chronic kidney disease in antiretroviral-Naïve patients with HIV/AIDS, J Int Assoc Provid AIDS Care, vol.14, issue.5, pp.434-474, 2015.

E. E. Abene, Z. M. Gimba, O. O. Agbaji, and E. I. Agaba, Prevalence of chronic kidney disease among antiretroviral naïve human immunodeficiency virus-infected patients, Sahel Med J, vol.21, issue.1, p.42, 2018.
DOI : 10.4103/smj.smj_53_16

K. H. Yao, M. C. Guehi, S. D. Konan, S. P. Diopoh, M. A. Moudachirou et al., Prevalence and risk factors for chronic kidney disease in general population of Yopougon (Côte d'ivoire); a cross-sectional study, J Ren Inj Prev, vol.7, issue.1, pp.27-32, 2017.

R. Oluyombo, O. E. Ayodele, P. O. Akinwusi, O. O. Okunola, A. Akinsola et al., A community study of the prevalence, risk factors and pattern of chronic kidney disease in Osun state, south West Nigeria, West Afr J Med, vol.32, issue.2, pp.85-92, 2013.

H. Zachor, R. Machekano, M. M. Estrella, P. J. Veldkamp, M. D. Zeier et al., Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimens, AIDS Lond Engl, vol.30, issue.8, pp.1221-1229, 2016.

M. M. Estrella, R. S. Parekh, A. Abraham, B. C. Astor, L. A. Szczech et al., The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women, J Acquir Immune Defic Syndr, vol.55, issue.2, pp.217-237, 2010.

J. R. Weinstein and S. Anderson, The aging kidney: physiological changes, Adv Chronic Kidney Dis, vol.17, issue.4, pp.302-309, 2010.

T. D. Mountokalakis, The renal consequences of arterial hypertension, Kidney Int, vol.51, issue.5, pp.1639-53, 1997.

A. I. Choi, M. G. Shlipak, P. W. Hunt, J. N. Martin, and S. G. Deeks, HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy, AIDS Lond Engl, vol.23, issue.16, pp.2143-2152, 2009.
DOI : 10.1097/qad.0b013e3283313c91

URL : http://europepmc.org/articles/pmc2839451?pdf=render

C. I. Bagnis and H. Stellbrink, Protease inhibitors and renal function in patients with HIV infection: a systematic review, 2015.

M. M. Mclaughlin, A. J. Guerrero, and A. Merker, Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV, Drugs Context, vol.7, p.212519, 2018.

S. Naicker, S. Rahmanian, and J. B. Kopp, HIV and chronic kidney disease, Clin Nephrol, vol.83, issue.7, pp.32-40, 2015.